Search

In Stock

Buy Symdeko (tezacaftor / ivacaftor) Online

DISEASE INDICATIONS: Cystic Fibrosis

MANUFACTURER: Vertex Pharmaceuticals (Europe) Ltd

USAGE: Oral

MEDICINE APPROVED BY:

European Medical Agency (EMA)

Food and Drug Administration (FDA)

, Symdeko is indicated for the treatment of patients with CF who have specific genetic mutations that are responsive to these medications. This combination therapy addresses the underlying cause of CF by improving the function of the CFTR (Cystic Fibrosis Transmembrane Conductance Regulator) protein, which is often dysfunctional in CF patients.

$39,418.95

Clear
Compare

Symdeko is a pharmaceutical medication that combines two active ingredients, tezacaftor and ivacaftor, to treat cystic fibrosis (CF). Specifically, Symdeko is indicated for the treatment of patients with CF who have specific genetic mutations that are responsive to these medications. This combination therapy addresses the underlying cause of CF by improving the function of the CFTR (Cystic Fibrosis Transmembrane Conductance Regulator) protein, which is often dysfunctional in CF patients.

Here is a detailed description of Symdeko, which is essentially a combination of tezacaftor and ivacaftor:

Name: Symdeko (Combination of Tezacaftor and Ivacaftor)

Active Ingredients:

  1. Tezacaftor: Tezacaftor is a CFTR corrector medication. It helps the defective CFTR protein in the cells of the respiratory system fold properly and move to the cell surface. This assists the CFTR protein in regulating the flow of salt and fluids in and out of the cells, leading to improved mucus clearance and reduced mucus thickness in the airways.
  2. Ivacaftor: Ivacaftor is a CFTR potentiator medication. It enhances the function of the CFTR protein that has reached the cell surface, increasing chloride ion transport. This further improves airway surface hydration and reduces the thickness of mucus, making it easier to clear.

Indications: Symdeko is indicated for the treatment of cystic fibrosis in patients who have specific genetic mutations. These mutations must be identified through genetic testing to determine if the patient is eligible for treatment with Symdeko.

Dosage Forms: Symdeko is available in the form of oral tablets, which are taken by mouth.

Usage: The dosing and administration of Symdeko are determined by a healthcare provider and are based on the patient’s age, weight, and specific genetic mutations. It is generally taken as prescribed, usually once or twice daily with fat-containing food to optimize absorption.

Benefits: Symdeko offers the potential to improve lung function, reduce respiratory symptoms, and enhance the overall quality of life for individuals with cystic fibrosis who have specific responsive mutations. While it is not a cure for CF, it can help manage the underlying genetic defect and improve the patient’s health and well-being.

Precautions: Patients must undergo genetic testing to identify the specific mutations that make them eligible for Symdeko treatment. It is crucial to use Symdeko as directed by a healthcare provider and to be aware of potential side effects and drug interactions.

Side Effects: Common side effects of Symdeko may include respiratory symptoms such as shortness of breath, cough, and chest tightness. Other possible side effects can include headache, nausea, and elevated liver enzymes. Patients should discuss any side effects or concerns with their healthcare provider.

In conclusion, Symdeko (tezacaftor/ivacaftor) is a combination medication used to treat cystic fibrosis in individuals with specific responsive mutations. It addresses the underlying genetic defect to improve lung function and reduce respiratory symptoms associated with CF. Patients should use it as directed by their healthcare provider and be aware of potential side effects and precautions associated with its use.

Package

28 tablets of 100 mg/150 mg

Reviews

There are no reviews yet.

Write a review

Your email address will not be published. Required fields are marked *

Bestsellers

Buy Symdeko (tezacaftor / ivacaftor) Online

$39,418.95
(0 Reviews)
DISEASE INDICATIONS: Cystic Fibrosis MANUFACTURER: Vertex Pharmaceuticals (Europe) Ltd USAGE: Oral MEDICINE APPROVED BY: European Medical Agency (EMA) Food and Drug Administration (FDA) , Symdeko is indicated for the treatment of patients with CF who have specific genetic mutations that are responsive to these medications. This combination therapy addresses the underlying cause of CF by improving the function of the CFTR (Cystic Fibrosis Transmembrane Conductance Regulator) protein, which is often dysfunctional in CF patients.

Buy Kalydeco (ivacaftor) Online

From $7,241.59
(0 Reviews)
DISEASE INDICATIONS: Cystic Fibrosis MANUFACTURER: Vertex Pharmaceuticals (Europe) Ltd USAGE: Oral MEDICINE APPROVED BY: European Medical Agency (EMA) Food and Drug Administration (FDA) Kalydeco (ivacaftor) is a medication prescribed for individuals with cystic fibrosis (CF) who are 4 months of age and older and possess at least one CF gene mutation that responds to Kalydeco treatment.

Buy Clenbuterol Harasawa Online

$102.85
(0 Reviews)
DISEASE INDICATIONS: Amyotrophic Lateral Sclerosis (ALS) MANUFACTURER: Harasawa USAGE: Oral MEDICINE APPROVED BY: Pharmaceuticals and Medical Devices Agency (PMDA) Clenbuterol, a medication employed in the management of individuals afflicted with bronchial asthma, chronic bronchitis, emphysema, acute bronchitis, or stress urinary incontinence, has diverse applications in the medical field. Notably, physicians occasionally opt for Clenbuterol's off-label use in the treatment of patients grappling with ALS (Amyotrophic Lateral Sclerosis). It's worth mentioning that Clenbuterol was previously recognized by its brand name, TONIL (clenbuterol).

Buy Breztri Aerosphere (budesonide/glycopyrrolate/formoterol fumarate) Online

$305.35
(0 Reviews)
DISEASE INDICATIONS: Chronic Obstructive Pulmonary Disease MANUFACTURER: AstraZeneca Pharmaceuticals LP USAGE: Oral MEDICINE APPROVED BY: Food and Drug Administration (FDA) Pharmaceuticals and Medical Devices Agency (PMDA)   Breztri Aerosphere is a pharmaceutical medication that is primarily used for the treatment of chronic obstructive pulmonary disease (COPD). This medication is designed to provide relief and management of the symptoms associated with COPD, which includes chronic bronchitis and emphysema.

Buy Lucaftor (lumacaftor/ivacaftor) Online

$3,054.56
(0 Reviews)
DISEASE INDICATIONS: Cystic Fibrosis MANUFACTURER: Gador SA USAGE: Oral MEDICINE APPROVED BY: ANMAT (ARG)   Lucaftor is not a standalone medication but a combination therapy that consists of two active ingredients: lumacaftor and ivacaftor. This combination medication is used for the treatment of a specific genetic disorder known as cystic fibrosis (CF). It is designed to address the underlying cause of CF in individuals who have a specific mutation in the CFTR (Cystic Fibrosis Transmembrane Conductance Regulator) gene.

Buy Trelegy Ellipta (fluticasone furoate/umeclidinium/vilanterol) Online

$755.34
(0 Reviews)
DISEASE INDICATIONS: Chronic Obstructive Pulmonary Disease, Asthma MANUFACTURER: GlaxoSmithKline USAGE: Oral MEDICINE APPROVED BY: European Medical Agency (EMA) Food and Drug Administration (FDA) Pharmaceuticals and Medical Devices Agency (PMDA)   It is used for the management of chronic obstructive pulmonary disease (COPD), a chronic respiratory condition characterized by breathing difficulties, coughing, and wheezing. This medication is designed to provide comprehensive treatment for COPD by addressing various aspects of the disease.

Buy Symkevi (tezacaftor/ivacaftor) Online

$5,729.85
(0 Reviews)
DISEASE INDICATIONS: Cystic Fibrosis MANUFACTURER: Vertex Pharmaceuticals (Europe) Ltd USAGE: Oral MEDICINE APPROVED BY: European Medical Agency (EMA) Food and Drug Administration (FDA) Symkevi is specifically designed to address the underlying genetic defect in individuals with CF who have specific responsive mutations.

Back to Top
Product has been added to your cart